Green Cross Surges 5.5% Amid Biosimilar (Generic Biopharmaceutical) Theme Rally

On August 5, the biosimilar (generic biopharmaceutical) theme showed strong performance, rising 3.84% compared to the previous day. Among related stocks, Green Cross (GC Pharma) surged 5.5% from the previous day. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

[Graph] Major Stock Price Changes in the Biosimilar (Generic Biopharmaceutical) Theme



According to analysis by Thinkpool’s robo-algorithm RASSI, Green Cross received a quant financial score of 27.61 points, ranking 14th within the biosimilar (generic biopharmaceutical) theme. This suggests that Green Cross is relatively less attractive from a financial investment perspective. In contrast, Dong-A ST ranked first in quant financial score due to its higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Financial Scores Within the Theme


* The quant financial score is the result of a robo-algorithm analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

* This article was automatically generated in real time by a news automation algorithm jointly developed by Asia Economy and Thinkpool, a financial AI specialist.

This content was produced with the assistance of AI translation services.